<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Stock Blog Hub &#187; DaVita Inc.</title>
	<atom:link href="http://www.stockbloghub.com/tag/davita-inc/feed" rel="self" type="application/rss+xml" />
	<link>http://www.stockbloghub.com</link>
	<description>Start Your Investing Research Here!</description>
	<lastBuildDate>Tue, 22 May 2012 18:53:06 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.3.2</generator>
		<item>
		<title>(JPM) JPMorgan Chase &amp; Company Returns to Form</title>
		<link>http://www.stockbloghub.com/2012/04/20/jpm-jpmorgan-chase-company-returns-to-form/98546</link>
		<comments>http://www.stockbloghub.com/2012/04/20/jpm-jpmorgan-chase-company-returns-to-form/98546#comments</comments>
		<pubDate>Fri, 20 Apr 2012 17:24:50 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Financial]]></category>
		<category><![CDATA[Money Center Banks]]></category>
		<category><![CDATA[BAC]]></category>
		<category><![CDATA[Bank of America Corporation]]></category>
		<category><![CDATA[C]]></category>
		<category><![CDATA[Citigroup Inc.]]></category>
		<category><![CDATA[DaVita Inc.]]></category>
		<category><![CDATA[DVA]]></category>
		<category><![CDATA[Goldman Sachs Group]]></category>
		<category><![CDATA[GS]]></category>
		<category><![CDATA[JPM]]></category>
		<category><![CDATA[JPMorgan Chase & Company]]></category>
		<category><![CDATA[Morgan Stanley]]></category>
		<category><![CDATA[MS]]></category>
		<category><![CDATA[Wells Fargo & Company]]></category>
		<category><![CDATA[WFC]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=98546</guid>
		<description><![CDATA[After profit declines for two straight quarters, JPMorgan Chase &#38; Company (JPM) reported first quarter earnings per share of $1.31, topping the Zacks Consensus Estimate of $1.17. This also compares favorably with $1.28 earned in the prior-year quarter. That’s more like the JPMorgan we have always known. JPMorgan’s better-than-expected earnings signals good going by the sector as it has exposure in almost all banking businesses. Marked recovery of the bond and equity market and consequent revenue growth, which helped JPMorgan to bounce back, should lift the results of other mega-banks during the quarter. JPMorgan’s earnings per share for the reported quarter included certain significant nonrecurring items, such as after-tax benefit from reduced loan loss reserves of 28 cents per share, after-tax benefit from the Washington Mutual bankruptcy settlement of 17 ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2012/04/20/jpm-jpmorgan-chase-company-returns-to-form/98546/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(JPM) JPMorgan Chase Earnings Preview</title>
		<link>http://www.stockbloghub.com/2012/04/20/jpm-jpmorgan-chase-earnings-preview-2/98488</link>
		<comments>http://www.stockbloghub.com/2012/04/20/jpm-jpmorgan-chase-earnings-preview-2/98488#comments</comments>
		<pubDate>Fri, 20 Apr 2012 17:15:25 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Financial]]></category>
		<category><![CDATA[Money Center Banks]]></category>
		<category><![CDATA[BAC]]></category>
		<category><![CDATA[Bank of America Corporation]]></category>
		<category><![CDATA[C]]></category>
		<category><![CDATA[Citigroup Inc.]]></category>
		<category><![CDATA[DaVita Inc.]]></category>
		<category><![CDATA[DVA]]></category>
		<category><![CDATA[Goldman Sachs Group]]></category>
		<category><![CDATA[GS]]></category>
		<category><![CDATA[JPM]]></category>
		<category><![CDATA[JPMorgan Chase & Company]]></category>
		<category><![CDATA[Morgan Stanley]]></category>
		<category><![CDATA[MS]]></category>
		<category><![CDATA[NIM]]></category>
		<category><![CDATA[Nuveen Select Maturities Municipal Fund]]></category>
		<category><![CDATA[Wells Fargo & Company]]></category>
		<category><![CDATA[WFC]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=98488</guid>
		<description><![CDATA[JPMorgan Chase &#38; Co. (JPM) is scheduled to report its first quarter 2012 results before the market opens on Friday, April 13. The Zacks Consensus Estimate for the quarter is $1.17 per share, representing a year-over-year slump of about 9%. After profit declines for two straight quarters, we expect JPMorgan to report impressive numbers this quarter as it is wont to do. Marked recovery of the bond and equity market and consequent revenue growth forms the basis of our assumption. Though there are fundamental pressures like low interest rates and sluggish loan demand growth on the sector, improving macroeconomic elements, such as rising consumer spending and lower unemployment, are expected to bring revenue stability for JPMorgan and the other major U.S. banks. However, JPMorgan has been fighting with poor capital market ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2012/04/20/jpm-jpmorgan-chase-earnings-preview-2/98488/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(DVA) DaVita Incorporated &#8211; Bull of the Day</title>
		<link>http://www.stockbloghub.com/2012/01/25/dva-davita-incorporated-bull-of-the-day/90800</link>
		<comments>http://www.stockbloghub.com/2012/01/25/dva-davita-incorporated-bull-of-the-day/90800#comments</comments>
		<pubDate>Wed, 25 Jan 2012 18:01:18 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Specialized Health Services]]></category>
		<category><![CDATA[DaVita Inc.]]></category>
		<category><![CDATA[DVA]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=90800</guid>
		<description><![CDATA[We are upgrading our recommendation on DaVita, Inc. (DVA) to Outperform based on the company&#8217;s strong cash flows and strategic acquisitions. The new bundled ESRD payment system is also expected to be a long-term positive. The company&#8217;s third-quarter earnings slightly exceeded the Zacks Consensus Estimate on the back of strong top-line growth, partially offset by higher operating expenses. Moreover, a strong cash position expands the potential for meaningful M&#38;A. While the acquisition of DSI should bring in new opportunities in most states, the company has to divest some of its centers as a condition. Nevertheless, we believe downside from current levels is likely limited. Our six-month target price of $96.00 equates to 19.0x our earnings estimate for 2011. This price target implies an expected total return of 20.3% over that ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2012/01/25/dva-davita-incorporated-bull-of-the-day/90800/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(DVA) DaVita Analyst Rating Steady at Neutral</title>
		<link>http://www.stockbloghub.com/2011/12/09/dva-davita-analyst-rating-steady-at-neutral/88267</link>
		<comments>http://www.stockbloghub.com/2011/12/09/dva-davita-analyst-rating-steady-at-neutral/88267#comments</comments>
		<pubDate>Fri, 09 Dec 2011 17:42:58 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Specialized Health Services]]></category>
		<category><![CDATA[DaVita Inc.]]></category>
		<category><![CDATA[DSI]]></category>
		<category><![CDATA[DVA]]></category>
		<category><![CDATA[Gentiva Health Services Inc.]]></category>
		<category><![CDATA[GTIV]]></category>
		<category><![CDATA[HEALTHSOUTH Corporation]]></category>
		<category><![CDATA[HLS]]></category>
		<category><![CDATA[iShares KLD 400 Social Index]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=88267</guid>
		<description><![CDATA[We have reiterated our Neutral recommendation on DaVita Inc. (DVA) based on strong top-line growth in the third quarter of 2011, which was partially offset by higher operating expenses. The company reported third-quarter operating earnings of $1.45 per share, exceeding the Zacks Consensus Estimate by a penny as well as $1.15 per share earned in the comparable quarter of 2010. DaVita has been generating strong operating cash flow, which increased at a 4-year CAGR (2007–2010) of 13.1%. Higher-than-expected cash flow during the first three quarters of 2011 also allowed the company to raise the 2011 operating cash flow guidance to $1.02–1.10 billion from $900–980 million. Additionally, DaVita has been following the strategy of growth through acquisitions. Acquisition of dialysis centers and businesses that own and operate dialysis centers, as well ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2011/12/09/dva-davita-analyst-rating-steady-at-neutral/88267/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(MS) Oct 19: The Earnings Parade Continues &#8211; Economic Highlights</title>
		<link>http://www.stockbloghub.com/2011/10/20/ms-oct-19-the-earnings-parade-continues-economic-highlights/85423</link>
		<comments>http://www.stockbloghub.com/2011/10/20/ms-oct-19-the-earnings-parade-continues-economic-highlights/85423#comments</comments>
		<pubDate>Thu, 20 Oct 2011 14:44:46 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Diversified Investments]]></category>
		<category><![CDATA[Financial]]></category>
		<category><![CDATA[AAPL]]></category>
		<category><![CDATA[Abbott Laboratories]]></category>
		<category><![CDATA[ABT]]></category>
		<category><![CDATA[American Express Company]]></category>
		<category><![CDATA[Apple Inc.]]></category>
		<category><![CDATA[AXP]]></category>
		<category><![CDATA[ConocoPhillips]]></category>
		<category><![CDATA[COP]]></category>
		<category><![CDATA[CSX]]></category>
		<category><![CDATA[CSX Corporation]]></category>
		<category><![CDATA[DaVita Inc.]]></category>
		<category><![CDATA[DVA]]></category>
		<category><![CDATA[EBAY]]></category>
		<category><![CDATA[eBay Inc.]]></category>
		<category><![CDATA[INTC]]></category>
		<category><![CDATA[Intel Corporation]]></category>
		<category><![CDATA[Marathon Oil Corporation]]></category>
		<category><![CDATA[MHP]]></category>
		<category><![CDATA[Morgan Stanley]]></category>
		<category><![CDATA[MRO]]></category>
		<category><![CDATA[MS]]></category>
		<category><![CDATA[Sara Lee Corporation]]></category>
		<category><![CDATA[SLE]]></category>
		<category><![CDATA[The McGraw-Hill Companies Inc]]></category>
		<category><![CDATA[United Technologies Corporation]]></category>
		<category><![CDATA[UTX]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=85423</guid>
		<description><![CDATA[The earnings parade continues even as the market tries to come to terms with the Apple surprise and waits for the expected weekend deal out of Europe. We also have economic data this morning about September CPI and Housing Starts, but they will likely have less traction in today&#8217;s market given the focus on earnings and Europe. The September CPI number was largely inline expectations, both on the &#8216;headline&#8217; as well as &#8216;core&#8217; basis. Given the recent pullback in commodity prices and the continued slack in the broader economy, inflation will likely have less staying power than would otherwise be the case. However, persistent &#8216;hot&#8217; CPI readings will make it difficult for Bernanke to rally all FOMC members behind him as we have seen in recent meetings. The Fed dissenters ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2011/10/20/ms-oct-19-the-earnings-parade-continues-economic-highlights/85423/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(MS) Ahead of Wall Street &#8211; October 19, 2011 &#8211; Ahead of Wall Street</title>
		<link>http://www.stockbloghub.com/2011/10/20/ms-ahead-of-wall-street-october-19-2011-ahead-of-wall-street/85469</link>
		<comments>http://www.stockbloghub.com/2011/10/20/ms-ahead-of-wall-street-october-19-2011-ahead-of-wall-street/85469#comments</comments>
		<pubDate>Thu, 20 Oct 2011 14:44:31 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Diversified Investments]]></category>
		<category><![CDATA[Financial]]></category>
		<category><![CDATA[AAPL]]></category>
		<category><![CDATA[Abbott Laboratories]]></category>
		<category><![CDATA[ABT]]></category>
		<category><![CDATA[American Express Company]]></category>
		<category><![CDATA[Apple Inc.]]></category>
		<category><![CDATA[AXP]]></category>
		<category><![CDATA[ConocoPhillips]]></category>
		<category><![CDATA[COP]]></category>
		<category><![CDATA[CSX]]></category>
		<category><![CDATA[CSX Corporation]]></category>
		<category><![CDATA[DaVita Inc.]]></category>
		<category><![CDATA[DVA]]></category>
		<category><![CDATA[EBAY]]></category>
		<category><![CDATA[eBay Inc.]]></category>
		<category><![CDATA[INTC]]></category>
		<category><![CDATA[Intel Corporation]]></category>
		<category><![CDATA[Marathon Oil Corporation]]></category>
		<category><![CDATA[MHP]]></category>
		<category><![CDATA[Morgan Stanley]]></category>
		<category><![CDATA[MRO]]></category>
		<category><![CDATA[MS]]></category>
		<category><![CDATA[Sara Lee Corporation]]></category>
		<category><![CDATA[SLE]]></category>
		<category><![CDATA[The McGraw-Hill Companies Inc]]></category>
		<category><![CDATA[United Technologies Corporation]]></category>
		<category><![CDATA[UTX]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=85469</guid>
		<description><![CDATA[Wednesday, October 19, 2011 The earnings parade continues even as the market tries to come to terms with the Apple surprise and waits for the expected weekend deal out of Europe. We also have economic data this morning about September CPI and Housing Starts, but they will likely have less traction in today&#8217;s market given the focus on earnings and Europe. The September CPI number was largely inline expectations, both on the &#8216;headline&#8217; as well as &#8216;core&#8217; basis. Given the recent pullback in commodity prices and the continued slack in the broader economy, inflation will likely have less staying power than would otherwise be the case. However, persistent &#8216;hot&#8217; CPI readings will make it difficult for Bernanke to rally all FOMC members behind him as we have seen in recent ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2011/10/20/ms-ahead-of-wall-street-october-19-2011-ahead-of-wall-street/85469/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(AMD) Company News for September 30, 2011 &#8211; Corporate Summary</title>
		<link>http://www.stockbloghub.com/2011/10/02/amd-company-news-for-september-30-2011-corporate-summary/84397</link>
		<comments>http://www.stockbloghub.com/2011/10/02/amd-company-news-for-september-30-2011-corporate-summary/84397#comments</comments>
		<pubDate>Sun, 02 Oct 2011 20:15:04 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Semiconductor - Broad Line]]></category>
		<category><![CDATA[Technology]]></category>
		<category><![CDATA[Advanced Micro Devices Inc.]]></category>
		<category><![CDATA[AMD]]></category>
		<category><![CDATA[BX]]></category>
		<category><![CDATA[C]]></category>
		<category><![CDATA[Citigroup Inc.]]></category>
		<category><![CDATA[DaVita Inc.]]></category>
		<category><![CDATA[DVA]]></category>
		<category><![CDATA[Family Dollar Stores Inc.]]></category>
		<category><![CDATA[FDO]]></category>
		<category><![CDATA[Harleysville Group Inc.]]></category>
		<category><![CDATA[HGIC]]></category>
		<category><![CDATA[Netease.com Inc]]></category>
		<category><![CDATA[NTES]]></category>
		<category><![CDATA[Perfect World Company Limited]]></category>
		<category><![CDATA[PWRD]]></category>
		<category><![CDATA[RAD]]></category>
		<category><![CDATA[Rite Aid Corporation]]></category>
		<category><![CDATA[The Blackstone Group]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=84397</guid>
		<description><![CDATA[•    Share prices of commercial insurer Harleysville Group Inc. (NASDAQ:HGIC) rocketed up 87.06% to $58.96 after Nationwide Mutual Insurance Co. announced its decision to buy Harleysville for $1.63 billion •    Analysts at Citi (NYSE:C) downgraded shares of dialysis-center operator DaVita Inc. (NYSE:DVA) from &#8220;Buy&#8221; rating to &#8220;Hold&#8221; rating •    Shares of Family Dollar Stores Inc. (NYSE:FDO) dropped 4.35% after shareholder Nelson Peltz officially cancelled his $7.7 billion offer to buy the retailer •    Semiconductor company Advanced Micro Devices&#8217; (NYSE:AMD) shares plunged 13.66% to close at $5.31 after the company lowered its guidance for the third quarter •    Shares of retail drugstore chain Rite Aid (NYSE:RAD) gained 2% after the company said same-store sales have increased by 1.3% year-over-year for September. However, sales from front-end same stores dropped 0.5% •    Analysts ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2011/10/02/amd-company-news-for-september-30-2011-corporate-summary/84397/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(FMS) Fresenius Medical Care Completes IDC Buy</title>
		<link>http://www.stockbloghub.com/2011/07/05/fms-fresenius-medical-care-completes-idc-buy/78359</link>
		<comments>http://www.stockbloghub.com/2011/07/05/fms-fresenius-medical-care-completes-idc-buy/78359#comments</comments>
		<pubDate>Wed, 06 Jul 2011 00:12:50 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Specialized Health Services]]></category>
		<category><![CDATA[DaVita Inc.]]></category>
		<category><![CDATA[DVA]]></category>
		<category><![CDATA[FMS]]></category>
		<category><![CDATA[FRESENIUS MED ADS]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=78359</guid>
		<description><![CDATA[Fresenius Medical Care (FMS), the largest provider of dialysis products and services on the planet, has wrapped up its acquisition of Euromedic International’s (“Euromedic”) dialysis service division International Dialysis Centers (“IDC”) for €485 million (roughly $648 million). This follows the regulatory approvals of the deal (announced in January 2011) by the anti-trust authorities. IDC provides treatment to over 8,200 hemodialysis patients mainly in Central and Eastern Europe and runs 70 clinics in nine nations. The acquisition enables Fresenius to expand its role in the dialysis care business, mainly in the fast-growing Eastern European markets, where IDC has a major presence. For its part, Euromedic will focus on cancer treatment and diagnostic arenas. The newly acquired business is expectedto contribute about $180 million in annual revenues for Fresenius. Moreover, the acquisition ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2011/07/05/fms-fresenius-medical-care-completes-idc-buy/78359/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(FMS) Fresenius Medical Care Offers Tips for Summer</title>
		<link>http://www.stockbloghub.com/2011/07/01/fms-fresenius-medical-care-offers-tips-for-summer/78213</link>
		<comments>http://www.stockbloghub.com/2011/07/01/fms-fresenius-medical-care-offers-tips-for-summer/78213#comments</comments>
		<pubDate>Fri, 01 Jul 2011 20:36:11 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Specialized Health Services]]></category>
		<category><![CDATA[DaVita Inc.]]></category>
		<category><![CDATA[DVA]]></category>
		<category><![CDATA[FMS]]></category>
		<category><![CDATA[FRESENIUS MED ADS]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=78213</guid>
		<description><![CDATA[Fresenius Medical Care (FMS), the largest provider of dialysis products and services in the globe, recently offered advice to renal patients to monitor their fluid intake during the parched summer months. Further, the company offered tips to dialysis patients on how to satisfy their thirst, without risking their well-being, during this period. Dialysis is a life-preserving mechanism that purifies the blood of waste substances and regulates the physical chemistry when an individual’s kidneys fail. Dialysis patients usually need treatment on a regular basis unless they are recipients of a kidney transplant. Fresenius Medical Care North America (“FMCNA”) observes that most people increase their fluid intake in order to stay hydrated in summer. However, excessive intake of liquids can lead to a serious life threatening situation for dialysis patients. The kidneys ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2011/07/01/fms-fresenius-medical-care-offers-tips-for-summer/78213/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(DVA) DaVita Beats Earnings Estimates on Revenues</title>
		<link>http://www.stockbloghub.com/2011/05/04/dva-davita-beats-earnings-estimates-on-revenues/73182</link>
		<comments>http://www.stockbloghub.com/2011/05/04/dva-davita-beats-earnings-estimates-on-revenues/73182#comments</comments>
		<pubDate>Wed, 04 May 2011 16:48:45 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Specialized Health Services]]></category>
		<category><![CDATA[Credit Suisse Group]]></category>
		<category><![CDATA[CS]]></category>
		<category><![CDATA[DaVita Inc.]]></category>
		<category><![CDATA[DVA]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=73182</guid>
		<description><![CDATA[DaVita Inc. (DVA) reported first-quarter net operating income of $94.5 million, or 96 cents per share, exceeding the Zacks Consensus Estimate by a penny. However, DaVita lagged the earnings of $109.4 million or $1.04 per share in the comparable quarter of 2010. This was attributable to better-than-expected revenues and strong cash flows of the company. However, higher operating expenses resulted in the decline. Net operating revenues for the reported quarter climbed 3.0% year-over-year to $1.61 billion, beating the Zacks Consensus Estimate of $1.60 billion. Total operating expenses and charges for the quarter climbed 4.3% year-over-year to $1.37 billion. DaVita’s quarterly consolidated operating income, including stock based compensation and equity investment income plummeted approximately 2.9% year-over-year to $236 million. Operating income margin for the reported quarter stood at 14.7% as opposed ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2011/05/04/dva-davita-beats-earnings-estimates-on-revenues/73182/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(A) Stock Market News for March 7, 2011 &#8211; Market News</title>
		<link>http://www.stockbloghub.com/2011/03/07/a-stock-market-news-for-march-7-2011-market-news/68182</link>
		<comments>http://www.stockbloghub.com/2011/03/07/a-stock-market-news-for-march-7-2011-market-news/68182#comments</comments>
		<pubDate>Tue, 08 Mar 2011 06:02:40 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Scientific & Technical Instruments]]></category>
		<category><![CDATA[Technology]]></category>
		<category><![CDATA[A]]></category>
		<category><![CDATA[Agilent Technologies Inc]]></category>
		<category><![CDATA[American Express Company]]></category>
		<category><![CDATA[AXP]]></category>
		<category><![CDATA[BAC]]></category>
		<category><![CDATA[Bank of America Corporation]]></category>
		<category><![CDATA[C]]></category>
		<category><![CDATA[Citigroup Inc.]]></category>
		<category><![CDATA[DaVita Inc.]]></category>
		<category><![CDATA[DVA]]></category>
		<category><![CDATA[EXPE]]></category>
		<category><![CDATA[Expedia Inc.]]></category>
		<category><![CDATA[GE]]></category>
		<category><![CDATA[General Electric Company]]></category>
		<category><![CDATA[Goldman Sachs Group]]></category>
		<category><![CDATA[GS]]></category>
		<category><![CDATA[Hewlett-Packard Company]]></category>
		<category><![CDATA[HPQ]]></category>
		<category><![CDATA[JDS Uniphase Corporation]]></category>
		<category><![CDATA[JDSU]]></category>
		<category><![CDATA[KB Home]]></category>
		<category><![CDATA[KBH]]></category>
		<category><![CDATA[Marvell Technology Group Limited]]></category>
		<category><![CDATA[MRVL]]></category>
		<category><![CDATA[Netflix Inc.]]></category>
		<category><![CDATA[NFLX]]></category>
		<category><![CDATA[RYL]]></category>
		<category><![CDATA[Ryland Group Inc.]]></category>
		<category><![CDATA[Weyerhaeuser Company]]></category>
		<category><![CDATA[WY]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=68182</guid>
		<description><![CDATA[Crude prices soared to more than $104 per barrel, the highest level since September 2008, following continued tension in Libya and dragged the markets lower on Friday. Not only did surging crude prices erase most of the gains for the week, it also negated the positive sentiment coming from the decline in unemployment rate. The fear gauge CBOE Volatility Index (VIX) jumped 2.7% to 19.11. The Dow Jones Industrial Average (DJIA) dropped 0.7% to close at 12,169.88. The Standard &#38; Poor 500 (S&#38;P 500) was down 0.7% and finished the day at 1,321.15. The Nasdaq Composite Index ended at 2,784.67 and shed 0.5%. On the New York Stock Exchange, NYSE Amex and Nasdaq, consolidated volumes were at 7.73 billion shares and below last year&#8217;s daily average of 8.47 billion. Weekly ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2011/03/07/a-stock-market-news-for-march-7-2011-market-news/68182/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(DVA) DaVita Prices $775 Million in Senior Notes</title>
		<link>http://www.stockbloghub.com/2010/10/08/dva-davita-prices-775-million-in-senior-notes/54536</link>
		<comments>http://www.stockbloghub.com/2010/10/08/dva-davita-prices-775-million-in-senior-notes/54536#comments</comments>
		<pubDate>Fri, 08 Oct 2010 16:33:49 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Specialized Health Services]]></category>
		<category><![CDATA[BAC]]></category>
		<category><![CDATA[Bank of America Corporation]]></category>
		<category><![CDATA[Barclays plc]]></category>
		<category><![CDATA[BCS]]></category>
		<category><![CDATA[Credit Suisse Group]]></category>
		<category><![CDATA[CS]]></category>
		<category><![CDATA[DaVita Inc.]]></category>
		<category><![CDATA[DVA]]></category>
		<category><![CDATA[Goldman Sachs Group]]></category>
		<category><![CDATA[GS]]></category>
		<category><![CDATA[JPM]]></category>
		<category><![CDATA[JPMorgan Chase & Company]]></category>
		<category><![CDATA[Liberty All Star Equity Fund]]></category>
		<category><![CDATA[USA]]></category>
		<category><![CDATA[Wells Fargo & Company]]></category>
		<category><![CDATA[WFC]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=54536</guid>
		<description><![CDATA[Moving ahead with its debt restructuring activity, on Tuesday, DaVita Inc. (DVA) announced the pricing of $775 million principal amount of 6?% senior notes due 2018 and $775 million principal amount of 6?% senior notes due 2020 totaling $1.55 billion. The net proceeds from the offering will be used to redeem another set of outstanding 6?% senior notes due 2013 and 7¼% senior subordinated notes due 2015. DaVita has appointed Banc of America Securities LLC, an arm of Bank of America Corp. (BAC), J.P. Morgan Securities LLC of JP Morgan Chase &#38; Co. (JPM), Credit Suisse Securities (USA) LLC of Credit Suisse Group (CS), Barclays Capital Inc. of Barclays plc (BCS), Goldman, Sachs &#38; Co. of Goldman Sachs Group Inc. (GS) and Wells Fargo Securities LLC of Wells Fargo &#38; ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2010/10/08/dva-davita-prices-775-million-in-senior-notes/54536/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(DVA) DaVita Plans $1.45 Billion Senior Notes</title>
		<link>http://www.stockbloghub.com/2010/10/05/dva-davita-plans-1-45-billion-senior-notes/54004</link>
		<comments>http://www.stockbloghub.com/2010/10/05/dva-davita-plans-1-45-billion-senior-notes/54004#comments</comments>
		<pubDate>Tue, 05 Oct 2010 15:32:18 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Specialized Health Services]]></category>
		<category><![CDATA[BAC]]></category>
		<category><![CDATA[Bank of America Corporation]]></category>
		<category><![CDATA[Barclays plc]]></category>
		<category><![CDATA[BCS]]></category>
		<category><![CDATA[Credit Suisse Group]]></category>
		<category><![CDATA[CS]]></category>
		<category><![CDATA[DaVita Inc.]]></category>
		<category><![CDATA[DVA]]></category>
		<category><![CDATA[Goldman Sachs Group]]></category>
		<category><![CDATA[GS]]></category>
		<category><![CDATA[JPM]]></category>
		<category><![CDATA[JPMorgan Chase & Company]]></category>
		<category><![CDATA[Liberty All Star Equity Fund]]></category>
		<category><![CDATA[USA]]></category>
		<category><![CDATA[Wells Fargo & Company]]></category>
		<category><![CDATA[WFC]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=54004</guid>
		<description><![CDATA[Moving ahead with its debt restructuring activity, on Friday DaVita Inc. (DVA) announced its plan to sell about $1.45 billion of its senior notes and utilize the net proceeds to redeem another set of outstanding senior security notes, whose principal amount is worth $1.55 billion. The Board of DaVita had authorized a $3.35 billion debt refinancing activity in September 2010. The $1.55 billion notes includes 6.625% senior notes worth $700 million to be matured in 2013 and another set of 7.25% senior notes worth $850 million slated to mature in 2015. Recently, DaVita also affirmed that it has taken up credit line borrowings in order to refinance debt worth $1.8 billion under its existing senior secured credit facilities. However,  the terms of the $1.45 billion notes offering are yet to ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2010/10/05/dva-davita-plans-1-45-billion-senior-notes/54004/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(FMS) Fresenius Medical Care Buys Asia Renal Care</title>
		<link>http://www.stockbloghub.com/2010/05/25/fms-fresenius-medical-care-buys-asia-renal-care/38386</link>
		<comments>http://www.stockbloghub.com/2010/05/25/fms-fresenius-medical-care-buys-asia-renal-care/38386#comments</comments>
		<pubDate>Tue, 25 May 2010 23:08:15 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Specialized Health Services]]></category>
		<category><![CDATA[DaVita Inc.]]></category>
		<category><![CDATA[DVA]]></category>
		<category><![CDATA[FMS]]></category>
		<category><![CDATA[FRESENIUS MED ADS]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=38386</guid>
		<description><![CDATA[Fresenius Medical Care (FMS) recently undertook a major expansion in dialysis services in the Asia-Pacific region by signing a sales and purchase agreement to acquire Asia Renal Care, a wholly owned subsidiary of Bumrungrad International, an associate company of Bumrungrad Hospital. If approved by the regulatory authorities in Taiwan and Singapore, the deal will add about $80 million to Fresenius Medical’s annual revenues. The transaction is expected to be accretive to earnings in the first year of operations. The markets for dialysis care in the Asia-Pacific region are expected to experience strong growth in the next five years with the number of patients slated to increase to more than 1 million from the current 680,000. Fresenius Medical is the dominant player followed by Asia Renal Care, which operates more than ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2010/05/25/fms-fresenius-medical-care-buys-asia-renal-care/38386/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(DVA) DaVita Shows Positive Earnings Surprises and Earnings Revisions</title>
		<link>http://www.stockbloghub.com/2010/03/12/dva-davita-shows-positive-earnings-surprises-and-earnings-revisions/30481</link>
		<comments>http://www.stockbloghub.com/2010/03/12/dva-davita-shows-positive-earnings-surprises-and-earnings-revisions/30481#comments</comments>
		<pubDate>Fri, 12 Mar 2010 18:55:58 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Specialized Health Services]]></category>
		<category><![CDATA[DaVita Inc.]]></category>
		<category><![CDATA[DVA]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=30481</guid>
		<description><![CDATA[Last month, DaVita Inc. (DVA), a leading provider of dialysis services in the United States to patients suffering from chronic kidney failure (also known as end stage renal disease (ESRD), announced its financial results for the fourth quarter and fiscal year ended Dec 31, 2009. Earnings estimates for 2010 are on the rise following the release of strong fourth quarter and full year 2009 results. The company earned $1.06 per share, which was well above the year-ago earnings of 94 cents. For full year 2009, DaVita earned $4.06 per share, in line with the Zacks Consensus Estimate but higher than the year-ago earnings of $3.53. Profits increased 12% from the year-ago quarter on higher revenues. Net operating revenue for fiscal 2009 climbed approximately 8% to $6.11 billion. As of Dec ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2010/03/12/dva-davita-shows-positive-earnings-surprises-and-earnings-revisions/30481/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(DVA) DaVita Tops Consensus Estimates</title>
		<link>http://www.stockbloghub.com/2009/11/04/dva-davita-tops-consensus-estimates/19660</link>
		<comments>http://www.stockbloghub.com/2009/11/04/dva-davita-tops-consensus-estimates/19660#comments</comments>
		<pubDate>Thu, 05 Nov 2009 00:17:49 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Specialized Health Services]]></category>
		<category><![CDATA[DaVita Inc.]]></category>
		<category><![CDATA[DVA]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=19660</guid>
		<description><![CDATA[DaVita Inc. (DVA) reported third quarter net income of $110.9 million or $1.06 per share, which was better than the Zacks Consensus Estimate of 99 cents. The company earned $93.9 million or 89 cents in the comparable quarter of 2008. Revenues for the quarter came in at $1.57 billion, which reflected an 8.3% increase over the year-ago quarter. According to segments, revenues from the Dialysis and Related Lab Services segment for the quarter came in at $1.49 billion as against $1.38 billion in the prior-year quarter. Other &#8211; Ancillary Services and Strategic Initiatives segment generated revenues of $83 million as against $69 million in the year-ago quarter. Highlights of the strong display in the reported quarter included consistent volume growth, stable private pricing and strong cash flows. Total treatments for ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2009/11/04/dva-davita-tops-consensus-estimates/19660/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(SNY) Healthcare Stocks…Are They Truly Recession-Proof?</title>
		<link>http://www.stockbloghub.com/2009/01/22/sny-healthcare-stocks%e2%80%a6are-they-truly-recession-proof/2311</link>
		<comments>http://www.stockbloghub.com/2009/01/22/sny-healthcare-stocks%e2%80%a6are-they-truly-recession-proof/2311#comments</comments>
		<pubDate>Fri, 23 Jan 2009 01:05:32 +0000</pubDate>
		<dc:creator>InvestmentU</dc:creator>
				<category><![CDATA[Drug Manufacturers - Major]]></category>
		<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[CAH]]></category>
		<category><![CDATA[Cardinal Health]]></category>
		<category><![CDATA[DaVita Inc.]]></category>
		<category><![CDATA[DCAI]]></category>
		<category><![CDATA[Dialysis Corp. of America]]></category>
		<category><![CDATA[DVA]]></category>
		<category><![CDATA[Glaxosmithkline plc]]></category>
		<category><![CDATA[GSK]]></category>
		<category><![CDATA[Inc.]]></category>
		<category><![CDATA[Novartis AG]]></category>
		<category><![CDATA[NVS]]></category>
		<category><![CDATA[Sanofi-Aventis]]></category>
		<category><![CDATA[SNY]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=2311</guid>
		<description><![CDATA[Healthcare Stocks…Are They Truly Recession-Proof? This past weekend, I was up at my hunting and fishing club in northeast Pennsylvania enjoying some ice fishing. At our club at least, it’s a pleasant social activity with great food, wine and stories shared among the members and spouses.This year, it happened to fall on the coldest day of the winter, with the temperature dipping to 18 below. As you might expect this close to the inauguration, many folks are wondering what effect President Obama’s policies will have on the markets and investing. One of our members who’s a doctor, said: “Invest in healthcare stocks. It doesn’t matter who’s in the Whitehouse, and they’re recession-proof.” Are they? The answer depends on what area of healthcare you’re talking about. According to Health Affairs, an ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2009/01/22/sny-healthcare-stocks%e2%80%a6are-they-truly-recession-proof/2311/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>

